How should acute laryngitis be managed?

Management of Acute Laryngitis

Acute laryngitis should be managed with expectant observation and symptomatic care alone, without antibiotics or corticosteroids, as it is a self-limited viral illness that resolves spontaneously in 1–3 weeks. 1

Initial Management: Observation and Vocal Rest

• Expectant observation is the recommended initial approach for new-onset dysphonia suspected to be viral laryngitis, as recommended by the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS). 1

• The condition typically resolves within 7–10 days to 3 weeks without any medical intervention. 1

• Vocal rest is the best treatment for acute laryngitis symptoms, particularly when related to vocal cord stress or overuse. 2

• The most common viral causes are parainfluenza, rhinovirus, influenza, and adenovirus. 1

What NOT to Prescribe: Antibiotics

Routine antibiotics are contraindicated for viral laryngitis and should not be prescribed. 1

• The AAO-HNS explicitly advises against prescribing antibiotics for dysphonia caused by viral laryngitis. 1

• Cochrane systematic reviews found no objective benefit of antibiotics in acute laryngitis when measuring objective voice outcomes. 3, 4

• Unnecessary antibiotic use exposes patients to adverse effects including rash, abdominal pain, diarrhea, vomiting, promotes antimicrobial resistance, and increases the risk of laryngeal candidiasis. 1

• While one study showed erythromycin reduced subjective voice disturbance at one week (RR 0.64, NNT 3.76), these modest subjective benefits do not outweigh the risks of antibiotic resistance and adverse effects. 3

• Reserve antibiotics only for immunocompromised patients or when bacterial infection is confirmed (e.g., laryngeal tuberculosis, pertussis, bacterial laryngotracheitis). 1

What NOT to Prescribe: Corticosteroids

Empiric systemic corticosteroids are not recommended for routine management of viral laryngitis. 1

• The AAO-HNS advises against routine steroid use due to limited evidence and significant risk profile. 1

• Steroid-related risks include avascular necrosis, pancreatitis, new-onset diabetes, laryngeal candidiasis, and dose-dependent pharyngitis. 1

• Selective use may be considered only in highly selected situations such as professional voice users with urgent vocal demands or allergic laryngitis, and only after shared decision-making discussing risks versus modest benefits. 1

When to Perform Laryngoscopy

Persistent dysphonia beyond 4 weeks mandates laryngoscopic evaluation to rule out alternative pathologies. 1

• Direct visualization of the larynx is the principal method to refine the differential diagnosis and guide targeted therapy. 1

• Early laryngoscopy is indicated when:

  • Serious underlying concerns exist at presentation (potential malignancy). 1
  • Professional voice users cannot wait for spontaneous recovery and need early assessment. 1
  • Symptoms persist beyond the expected 1–3 week viral course, raising suspicion for alternative pathologies. 1

• Early laryngoscopy helps prevent delays in diagnosing malignancy or other serious conditions. 1

• For chronic laryngitis (symptoms >3 weeks), visualization of the vocal cords is essential to rule out malignant lesions, nodules, or polyps. 2

Common Pitfalls to Avoid

• Do not reflexively prescribe antibiotics for hoarseness when a bacterial cause is not evident; most cases are viral. 1

• Do not use steroids empirically without a documented indication and shared decision-making. 1

• Do not delay laryngoscopy beyond 4 weeks in patients with persistent dysphonia to avoid postponing diagnosis of serious disease. 1

• Do not prescribe anti-reflux medication empirically for hoarseness unless the patient has GERD symptoms or laryngoscopic evidence of chronic laryngitis. 1

• Do not use decongestants as they should be discouraged in the management of acute laryngitis. 2